Inventor · disambiguated record
Michael E. Goldberg
Also filed as: GOLDBERG MICHAEL · GOLDBERG MICHAEL E
13 granted patents·5 pending applications·228 citations·filing 1998–2025
91Inventor score
Files withCOOPER HEALTH SYSTEM2THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2US HEALTH2COOPER HEALTH SYSTEM INC1SYBASE INC1
Top patents by PatentIndex Score
18 records- 0192US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0292US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0390US6479063B2Therapeutic uses of hormonal manipulation using combinations of various agents to treat atherosclerosisFiled 2000·Granted Nov 12, 2002·43 cites·12 claims
- 0490US6099851ATherapeutic uses of leuprolide acetateFiled 1998·Granted Aug 8, 2000·118 cites·6 claims
- 0578US7856498B2Collaborative alert management and monitoringSYBASE INC·Filed 2008·Granted Dec 21, 2010·7 cites·32 claims
- 0677US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0774US6197337B1Therapeutic uses of abarelixFiled 2000·Granted Mar 6, 2001·5 cites·4 claims
- 0873US6534537B2Use of HMG-COA reductase inhibitors to prevent and treat BPHFiled 2001·Granted Mar 18, 2003·4 cites·9 claims
- 0971US6630164B2Dutasteride to prevent and treat atherosclerosisFiled 2001·Granted Oct 7, 2003·3 cites·3 claims
- 1068US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 1167US6627227B2Use of saw palmetto to prevent atherosclerosisFiled 2001·Granted Sep 30, 2003·1 cites·3 claims
- 1259US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
- 1351US7528172B2Compositions and methods for improving recovery after general anesthesiaCOOPER HEALTH SYSTEM INC·Filed 2003·Granted May 5, 2009·1 cites·1 claims
- 1446US2009264720A1Wearable Automated Blood Sampling and Monitoring SystemCOOPER HEALTH SYSTEM·Filed 2008·Application pending·0 cites
- 1538US2016195409A1Monitoring systemXEROS LTD·Filed 2015·Application pending·0 cites
- 1637US6140315ATherapeutic uses of goserelin acetateFiled 1998·Granted Oct 31, 2000·4 cites·3 claims
- 1735US6090409ATherapeutic uses of finasterideFiled 1998·Granted Jul 18, 2000·3 cites·3 claims
- 1822US7169768B1Method of decreasing atherosclerosis and its complicationsWEISMAN KENNETH M·Filed 1998·Granted Jan 30, 2007·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Michael E. Goldberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →